SDHB and neoplasm: Our laboratory recently performed a metabolomic analysis of SDHB_KD, SDHB-mutant human progenitor cells developed from hPheo1, a physiologically relevant PCC patient-derived cell line [6] and discovered an overactive polyamine pathway subsequently fully validated in human PPGL SDHB-mutant tumor samples [7].